Advertisement
Screener

RAFAEL HOLDINGS, INC. (RFL) Other Comprehensive Income (Loss), Tax

2.8 / 5 stars · 68/120 Roast Me

RAFAEL HOLDINGS, INC. Other Comprehensive Income (Loss), Tax

RAFAEL HOLDINGS, INC. (RFL) reported Other Comprehensive Income (Loss), Tax of $0 for the 3-month period ending 2025-04-30, per its 10-Q filed 2025-06-11.

Financial Statements › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossTax · last filed 2025-06-11

  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2025-04-30 was $0.00, a 100.00% decline year-over-year.
  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2025-01-31 was $0.00, a 100.00% decline year-over-year.
  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-10-31 was $0.00, a 100.00% decline year-over-year.
  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-07-31 was $18.00K, a 82.35% decline year-over-year.
  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2024 was $20.00K.
  • RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2023 was $0.00.
Period endOther Comprehensive Income (Loss), Tax 3 monthOther Comprehensive Income (Loss), Tax 6 monthOther Comprehensive Income (Loss), Tax 9 monthOther Comprehensive Income (Loss), Tax 12 month
2025-04-30$0.00
10-Q · filed 2025-06-11
$0.00
derived: sum of 2 quarters · filed 2025-06-11
$0.00
10-Q · filed 2025-06-11
$18.00K
derived: sum of 4 quarters · filed 2025-06-11
2025-01-31$0.00
10-Q · filed 2025-03-14
$0.00
10-Q · filed 2025-03-14
$18.00K
derived: sum of 3 quarters · filed 2025-03-14
$20.00K
derived: sum of 4 quarters · filed 2025-06-11
2024-10-31$0.00
10-Q · filed 2024-12-11
$18.00K
derived: sum of 2 quarters · filed 2024-12-20
$20.00K
derived: sum of 3 quarters · filed 2025-06-11
$22.00K
derived: sum of 4 quarters · filed 2025-06-11
2024-07-31$18.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20
$20.00K
derived: sum of 2 quarters · filed 2025-06-11
$22.00K
derived: sum of 3 quarters · filed 2025-06-11
$20.00K
10-K/A · filed 2024-12-20
2024-04-30$2.00K
10-Q · filed 2025-06-11
$4.00K
derived: sum of 2 quarters · filed 2025-06-11
$2.00K
10-Q · filed 2025-06-11
$108.00K
derived: sum of 4 quarters · filed 2025-06-11
2024-01-31$2.00K
10-Q · filed 2025-03-14
$2.00K
10-Q · filed 2025-03-14
$106.00K
derived: sum of 3 quarters · filed 2025-03-14
$4.00K
derived: sum of 4 quarters · filed 2025-03-14
2023-10-31$2.00K
10-Q · filed 2024-12-11
$104.00K
derived: sum of 2 quarters · filed 2024-12-20
$2.00K
derived: sum of 3 quarters · filed 2024-12-20
2023-07-31$102.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20
$0.00
derived: sum of 2 quarters · filed 2024-12-20
$0.00
10-K/A · filed 2024-12-20
2023-04-30-$102.00K
10-Q · filed 2023-06-13
-$102.00K
10-Q · filed 2023-06-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aditxt, Inc. (ADTX)United States$0.000B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B